Richard Bucala
- Clinical Biochemistry top 1%
- Endocrinology, Diabetes and Metabolism top 5%
- Pathology and Forensic Medicine
- Nephrology top 10%
- Physiology
- Co-authors
- Zenji MakitaIain D. NichollYukihiko KamedaTakao KoikeTakako SuzukiHelen VlassaraThomas J. CurpheyTruls Brinck‐Johnsen
- Topics
- Advanced Glycation End Products research (6 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers)Nuclear Receptors and Signaling (2 papers)
- Partner nations
- United StatesEthiopiaPuerto Rico
In The Last Decade
Richard Bucala
9 papers receiving 520 citations
Peers
Comparison fields: 5 of 69
- Clinical Biochemistry 390
- Endocrinology, Diabetes and Metabolism 217
- Pathology and Forensic Medicine 81
- Nephrology 72
- Physiology 68
Countries citing papers authored by Richard Bucala
This map shows the geographic impact of Richard Bucala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bucala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bucala more than expected).
Fields of papers citing papers by Richard Bucala
This network shows the impact of papers produced by Richard Bucala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bucala. The network helps show where Richard Bucala may publish in the future.
Co-authorship network of co-authors of Richard Bucala
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Bucala. A scholar is included among the top collaborators of Richard Bucala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Bucala. Richard Bucala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 23 | |
| 3 | Abstract P215: Role for Reduced MIF Secretion in Attenuated AMPK Activation and Ischemic Recovery in the Senescent Heart | 1 |
| 4 | Advanced glycation end products are increased in non-diabetic patients with obstructive sleep apnea but to a lesser degree than type 2 diabetic patients | 3 |
| 5 | 173 | |
| 6 | 20 | |
| 7 | Advanced glycation endproducts and cigarette smoking. | 101 |
| 8 | Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy (food nonenzymatic glycation productsyrenalyvascularydiabetes diseaseyglycotoxinsyMaillard products) | 2 |
| 9 | 209 |
About Richard Bucala
Richard Bucala is a scholar working on Clinical Biochemistry, Ophthalmology and Complementary and alternative medicine, having authored 9 papers that have together received 535 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Nuclear Receptors and Signaling (2 papers). The work is most often cited by research in Clinical Biochemistry (390 citations), Endocrinology, Diabetes and Metabolism (217 citations) and Nephrology (72 citations). Richard Bucala has collaborated with scholars based in United States, Ethiopia and Puerto Rico. Frequent co-authors include Zenji Makita, Iain D. Nicholl, Yukihiko Kameda, Takao Koike, Takako Suzuki, Helen Vlassara, Thomas J. Curphey, Truls Brinck‐Johnsen, Paul J. Beisswenger and Lynn L. Moore. Their work appears in journals such as Circulation, Diabetes and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.